Q3: Divine Skin Announces Record Quarterly Net Revenue of $1.52 million and Third Quarterly Net Income

MIAMI BEACH, Fla., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Today biotech pioneer Divine Skin Inc. (OTC Bulletin Board: DSKX), which went public less than a year ago, announced its third consecutive quarterly net income.

• Q3 net revenue grew to $1.52 million — up 17 percent from last quarter and up 59 percent from the same quarter of 2009.
• For the first nine months of 2010, net revenue increased to $3.82 million — up $1.17 million or 44 percent from the $2.65 million of the first nine months of 2009.
• Q3 profit increased to $85,656 — up $218,669 or 164 percent from the loss of $133,013 in the same quarter of 2009.
• For the first nine months of 2010, net income increased to $345,268 — up $422,896 or 544 percent from the $77,628 loss of the first nine months of 2009.

CEO Daniel Khesin attributed much of the growth to expanding demand for the company's consumer products. "We continue to face difficulties meeting demand from our customers, which places a strain on our supply chain and operations. Resolving these challenges is now our top priority and will lead to significant increases in revenue once we are successful. There was a lot of frustration in Q3 from our customers, who were receiving orders late due to product shortages."

Divine Skin defied the recent economic slowdown, growing quickly and without investment capital until 2009, when the developer of dermatological treatments conducted a private placement. The company began trading publicly on May 20, 2010.

Divine Skin's strategy has been to formulate effective new products by combining active ingredients already approved in existing monographs at the US Food and Drug Administration. The company thus avoids lengthy approval processes while achieving maximum efficacy and delivering new high-performance products quickly.

The company's first brand, DS Laboratories, established itself with comprehensive minoxidil-based and minoxidil-free treatments for hair restoration. This line, called Spectral, competes head-to-head with McNeil's Rogaine, which contains only one active ingredient.

About Divine Skin

Divine Skin Inc. develops, markets, and distributes personal-care products through cosmetics wholesalers, online retailers, specialty outlets, spas, salons, and medical offices in more than 20 countries. Its brands include DS Laboratories, Sigma Skin, and Polaris Research.

DS Laboratories, the flagship brand, offers high-performance topical solutions for men and women to restore growth and radiance to hair; suppress dandruff and unwanted hair; control acne; maintain feminine hygiene; and reduce the appearance of cellulite, wrinkles, and double chins (www.dslaboratories.com).

The Sigma Skin brand targets men and sells through upscale retailers like Bergdorf Goodman and Neiman Marcus in the United States, Saks Fifth Avenue in Mexico, and Harvey Nichols in the United Kingdom. Products are designed to reverse hair loss and other signs of aging (www.sigmaskin.com).

Polaris Research makes high-potency minoxidil-based hair-growth formulas (www.polarisresearch.co.uk).

Pure Guild, the newest brand, offers purity with performance. Botanical compounds proven most effective in rigorous clinical trials are extracted mechanically, using no industrial solvents or damaging heat. The uncompromised treatments sell through ultra-premium food retailers (www.thepureguild.com).

Divine Skin's management believes the company has established itself as a leader in topical therapies, especially hair-growth, through aggressive pursuit of innovation and technology. Products employ comprehensive formulas with multiple methods of action against common skin conditions. Many utilize proprietary encapsulation techniques for improved bioavailability.

SOURCE Divine Skin Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED